Influencing Factors and Predictors of Early Response in Schizophrenia Patients Receiving the Paliperidone Extended-Release Tablets (Paliperidone ER)

OBJECTIVE: Paliperidone extended-release tablet (paliperidone ER) is a new oral psychotropic agent developed for schizophrenia treatment. There have been some studies about paliperidone's good efficacy and tolerability. Clinicians appear to change the antipsychotic medication to paliperidone ER...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Jung, Seung-Ho, Yoon, Jin-Sang, Ahn, Yong-Min, Kim, Yong-Sik, Kim, Chul-Eung
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Korean Neuropsychiatric Association 2013
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3902160/
https://ncbi.nlm.nih.gov/pubmed/24474991
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4306/pi.2013.10.4.407
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia